Back to search

Italy· 039056027

BERINERT*1 flaconcino polv EV 1.500 UI + 1 flaconcino solv 3 ml + set

A medicinal product containing proteina del plasma umano antiangioedema, registered in Italy by CSL BEHRING GmbH, on the national reimbursement list.

Reimbursed in Italy (AIFA class A)

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedBERINERT*1 flaconcino polv EV 1.500 U…ATC—REGISTER NO.039056027PACKS LISTED1CHECKEDJune 4, 2026

The record

At a glance

Active substance
Proteina del plasma umano antiangioedema
Manufacturer
CSL BEHRING GmbH
Country
Italy (IT)
ATC code
—
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    039056027
    BERINERT*1 flaconcino polv EV 1.500 UI + 1 flaconcino solv 3 ml + set
    EUR 2772.67

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f5a538a1-9c8c-4fce-aca0-0b5be95ce1dc
GET /v1/drugs/f5a538a1-9c8c-4fce-aca0-0b5be95ce1dc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 2772.67,
  "source": "aifa",
  "currency": "EUR",
  "strength": "PROTEINA DEL PLASMA UMANO ANTIANGIOEDEMA 1.500U 1 UNITA' USO PARENTERALE",
  "substance": "Proteina del plasma umano antiangioedema",
  "equivalence_group": "JJX",
  "transparency_flag": null
}

See everything about proteina del plasma umano antiangioedema.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.